Unleash the potential of CRISPR with BTX Electroporation Systems
Your current CRISPR technology may be limiting the potential of your CRISPR applications. Electroporation has become the method of choice for CRISPR gene editing applications, quickly overtaking traditional methods such as chemical reagents or microinjection.
BTX has been in the forefront of electroporation technology since introducing the first commercial electroporator in 1983. Our latest electroporation instruments are leading the charge for CRISPR gene editing applications! BTX Gemini and ECM 830 Electroporation Systems provide efficient, reproducible delivery of CRISPR/Cas 9, guide RNA, and homologous repair donor constructs to virtually any cell or tissue of interest.
Gemini Twin Wave Universal Electroporation System
These flexible twin wave systems allow both square wave and exponential decay wave electroporation in a single unit. Ideal for CRISPR and many other electroporation applications including, in vivo, in vitro, in ovo and more.
Software includes preset CRISPR protocols for mammalian cells and tissues, bacteria, and other microorganisms.
Choose Gemini SC for cuvette-based in vitro transfections of any cell type in suspension.
With Gemini X2, transfect any cell or tissue using cuvettes, high throughput electroporation plates, and in vivo specialty electrode formats.
BTX® is a division of Harvard Bioscience, Inc. All Rights Reserved.